Meeting
2015 Gastrointestinal Cancers Symposium
Impact of sarcopenia (Sp) on outcomes in patients (pts) undergoing trimodality therapy for esophageal cancer.
Authors
Brian Weston
Fox Chase Cancer Center, Philadelphia, PA
Brian Weston , Talha Shaikh , Elizabeth Handorf , Walter Joseph Scott , Steven J. Cohen , Joshua E. Meyer
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 33, 2015 (suppl 3; abstr 221)
DOI
10.1200/jco.2015.33.3_suppl.221
Abstract #
221
Poster Bd #
E17
Abstract Disclosures
Similar Posters
Poster
2013 Gastrointestinal Cancers Symposium
Survival in patients with esophageal cancer treated with surgery after chemoradiotherapy.
First Author: Ravi Shridhar
Poster
2019 ASCO Annual Meeting
PET-directed combined modality therapy for gastroesophageal junction cancer: First results of the prospective MEMORI trial.
First Author: Sylvie Lorenzen
Poster
2019 ASCO Annual Meeting
Angiosarcoma of bone: A European Muscoloskeletal Oncology Society (EMSOS) multicenter, retrospective study.
First Author: Emanuela Palmerini
Poster
2019 Gastrointestinal Cancers Symposium
A multicenter study of trimodality therapy for patients 75 years and older with esophageal cancer.
First Author: Niamh Anna McDonnell